EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 52021M10141
Prior notification of a concentration (Case M.10141 — Sanacorp Pharmahandel/Leopold Fiebig and Gerda Nückel) (Text with EEA relevance) 2021/C 47/08
Prior notification of a concentration (Case M.10141 — Sanacorp Pharmahandel/Leopold Fiebig and Gerda Nückel) (Text with EEA relevance) 2021/C 47/08
Prior notification of a concentration (Case M.10141 — Sanacorp Pharmahandel/Leopold Fiebig and Gerda Nückel) (Text with EEA relevance) 2021/C 47/08
PUB/2021/108
OJ C 47, 10.2.2021, p. 10–11
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
10.2.2021 |
EN |
Official Journal of the European Union |
C 47/10 |
Prior notification of a concentration
(Case M.10141 — Sanacorp Pharmahandel/Leopold Fiebig and Gerda Nückel)
(Text with EEA relevance)
(2021/C 47/08)
1.
On 1 February 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).This notification concerns the following undertakings:
|
— |
Leopold Fiebig GmbH & Co. KG (Germany), |
|
— |
Gerda Nückel GmbH (Germany), |
|
— |
Sanacorp Pharmahandel GmbH (Germany), ultimately controlled by astera SA (France) and Sanacorp eG Pharmazeutische Großhandlung (Germany). |
Sanacorp Pharmahandel GmbH acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Leopold Fiebig GmbH & Co. KG and Gerda Nückel GmbH.
The concentration is accomplished by way of purchase of shares.
2.
The business activities of the undertakings concerned are:|
— |
Sanacorp Pharmahandel GmbH is a full-service wholesaler of pharmaceuticals operating on the German market. |
|
— |
Leopold Fiebig GmbH & Co. KG is a full-service wholesaler of pharmaceuticals based in Rheinstetten, operating in central and southern Germany. |
|
— |
Gerda Nückel GmbH is the general partner of Leopold Fiebig GmbH & Co. KG. |
3.
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
4.
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.10141 — Sanacorp Pharmahandel/Leopold Fiebig and Gerda Nückel
Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Fax +32 22964301
Postal address:
|
European Commission |
|
Directorate-General for Competition |
|
Merger Registry |
|
1049 Bruxelles/Brussel |
|
BELGIQUE/BELGIË |
(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).